EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseOpen Access · CC BY-NC-ND 4.0

Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors

David V Sheehan, Michele Mancini, Jianing Wang, Lovisa Berggren, Haijun Cao, Héctor José Dueñas, Li Yue

Human Psychopharmacology: Clinical and Experimental · 2016-01 · 31 (1) · 53-63

DOI: 10.1002/hup.2500 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, 2015-09. Verfasst von David V Sheehan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Morsani College of Medicine, University of South Florida, Tampa, Florida, USA. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Lilly Suzhou Pharmaceutical Company Ltd, Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAntidepressive AgentsMajor Depressive DisorderDisability EvaluationDuloxetine HydrochlorideFemaleHumansLogistic ModelsMaleMiddle AgedPsychiatric Status Rating ScalesRandomized Controlled Trials as TopicSelective Serotonin Reuptake InhibitorsTreatment Outcome

Stichwörter der Autor:innen

HAMD-17MADRSSDSSSRIsduloxetineremission

Substanzen

Antidepressive AgentsDuloxetine HydrochlorideSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.
  • Eli Lilly and Company, Bad Homburg, Germany.
  • Lilly Suzhou Pharmaceutical Company Ltd, Shanghai, China.
  • Lilly Emerging Markets, Mexico City, Mexico.

Förderung

  • Lilly Suzhou Pharmaceutical Company Ltd
  • Eli Lilly and Company

Zitieren

APA

Sheehan, D. V., Mancini, M., Wang, J., Berggren, L., Cao, H., Dueñas, H. J., & Yue, L. (2016). Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors. Human Psychopharmacology: Clinical and Experimental, 31(1), 53-63. https://doi.org/10.1002/hup.2500

Vancouver

Sheehan DV, Mancini M, Wang J, Berggren L, Cao H, Dueñas HJ, et al. Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors. Human Psychopharmacology: Clinical and Experimental. 2016;31(1):53-63. doi:10.1002/hup.2500

BibTeX
@article{Sheehan2016,
  author = {Sheehan, David V and Mancini, Michele and Wang, Jianing and Berggren, Lovisa and Cao, Haijun and Dueñas, Héctor José and Yue, Li},
  title = {Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors},
  journal = {Human Psychopharmacology: Clinical and Experimental},
  year = {2016},
  volume = {31},
  number = {1},
  pages = {53--63},
  doi = {10.1002/hup.2500}
}
Kostenlos starten →